1. Home
  2. Health and social care
  3. Public health
  4. Health improvement

Drug misuse and dependency

On this page

Services

  1. Misuse of drugs: annual statement of compliance

    Annual statement of compliance with the requirements of the misuse of drugs legislation for year ending 31 December 2008.

  2. ACMD open meeting 12 June 2014: registration form

    Complete this form to attend the 'Diversion and Illicit Supply of Medicines Inquiry – Evidence Gathering' open meeting of the Advisory Council on the Misuse of Drugs.

See more services in this topic

Guidance and regulation

  1. Controlled drugs list
    • Guidance
    • Home Office
  2. Drug misuse and dependence: UK guidelines on clinical management
    • Guidance
    • Department of Health and Social Care
  3. Precursor chemical licensing
    • Detailed guide
    • Home Office
  4. Young people drug and alcohol treatment business definitions
    • Guidance
    • Public Health England
  5. FRANK posters
    • Promotional
    • Home Office
See more guidance and regulation in this topic

News and communications

Correspondence

Advice on 2,4-Dinitrophenol

Advisory Council on the Misuse of Drugs

  1. Prescribing of controlled drugs by therapeutic radiographers: further advice
    • Advisory Council on the Misuse of Drugs
    • Correspondence
  2. Circular 018/2018: rescheduling of cannabis-based products for medicinal use in humans
    • Home Office
    • Correspondence
  3. Advice on the anticonvulsant drugs Pregabalin and Gabapentin
    • Advisory Council on the Misuse of Drugs
    • Correspondence
  4. Cannabis-derived medicinal products to be made available on prescription
    • Home Office
    • News story
See more news and communications in this topic

Research and statistics

  1. Substance misuse treatment in secure settings: 2017 to 2018
    • Public Health England
    • Official statistics
  2. Public Health NI - Fact Sheet 2018
    • Northern Ireland Statistics and Research Agency and Department of Health (Northern Ireland)
    • Official statistics
  3. Substance misuse treatment for young people: statistics 2017 to 2018
    • Public Health England
    • National statistics
  4. Review of the Psychoactive Substances Act 2016
    • Home Office
    • Research
  5. Forensic early warning system (FEWS) annual report
    • Home Office
    • Research
See more research and statistics in this topic

Policy papers and consultations

  1. Prescribed medicines review: expert group terms of reference
    • Public Health England
    • Policy paper
  2. Cannabis-based medicines expert panel: terms of reference
    • Home Office
    • Policy paper
  3. Drug strategy 2017
    • Home Office
    • Policy paper
  4. Plant cannabinoids: ACMD report
    • Advisory Council on the Misuse of Drugs
    • Policy paper
  5. Diversion & illicit supply of medicines
    • Advisory Council on the Misuse of Drugs
    • Policy paper
See more policy papers and consultations in this topic

Transparency and freedom of information releases

  1. Commissioning impact on drug treatment
    • Advisory Council on the Misuse of Drugs
    • Corporate report
  2. Drug strategy 2016: development review
    • Advisory Council on the Misuse of Drugs
    • Corporate report
  3. Psychoactive Substances Bill: evaluation review
    • Advisory Council on the Misuse of Drugs
    • Corporate report
  4. Methiopropamine: a review of the evidence of use and harm
    • Advisory Council on the Misuse of Drugs
    • Corporate report
  5. Methylphenidate base and methylphenidate hydrochloride importation, 2010 to 2012
    • Home Office
    • Foi release
See more transparency and freedom of information releases in this topic

Organisations

Show more organisations